Clinical characteristics | Cognitive impairment no | Cognitive impairment yes | Total | p value | |||
---|---|---|---|---|---|---|---|
(n = 123) | (n = 128) | (n = 251) | |||||
Previous medical history, n (%) | |||||||
High blood pressure (HBP) | |||||||
Slight HBP | 81 | (65.9) | 75 | (58.6) | 156 | (62.2) | 0.606 |
Moderate HBP | 20 | (16.3) | 23 | (18.0) | 43 | (17.1) | |
Severe HBP | 3 | (2.4) | 5 | (3.9) | 8 | (3.2) | |
Without HBP | 19 | (15.4) | 25 | (19.5) | 44 | (17.5) | |
Diabetes mellitus, n (%) | 29 | (23.6) | 31 | (24.2) | 60 | (23.9) | 0.905 |
Hypothyroidism, n (%) | 34 | (27.6) | 41 | (32.0) | 75 | (29.9) | 0.377 |
Stroke, n (%) | 10 | (8.1) | 12 | (9.4) | 22 | (8.8) | 0.742 |
Smoking, n (%) | 33 | (26.8) | 35 | (27.3) | 68 | (27.1) | 0.927 |
Anemia, n (%) | – | – | 4 | (3.1) | 4 | (1.6) | – |
Sedentary lifestyle, n (%) | 64 | (52.0) | 72 | (56.3) | 136 | (54.2) | 0.417 |
Alcohol consumptionb, n (%) | 8 | (6.5) | 6 | (4.7) | 14 | (5.6) | 0.541 |
Glomerular filtration rate, ml/min, median (IQR) | 44 | (37–49) | 39.5 | (31–48) | 42 | (34–48) | 0.028 |
Stage 3 chronic kidney disease, n (%) | 110 | (89.4) | 107 | (83.6) | 217 | (86.5) | 0.177 |
Stage 4 chronic kidney disease, n (%) | 13 | (10.6) | 21 | (16.4) | 34 | (13.5) | |
Cause of kidney disease, n (%) | |||||||
Diabetes | 21 | (17.1) | 27 | (21.1) | 48 | (19.1) | 0.750 |
HBP | 89 | (72.4) | 81 | (63.3) | 170 | (67.7) | |
Glomerulonephritis | 1 | (0.8) | 4 | (3.1) | 5 | (2.0) | |
Obstructive condition | 6 | (4.9) | 10 | (7.8) | 16 | (6.4) | |
Unknown | 6 | (4.9) | 6 | (4.7) | 12 | (4.8) | |
Body mass index, kg/mt2, median (IQR)a | 24 | (23–27) | 25 | (22–27) | 25 | (23–27) | 0.908 |
Normal | 58 | (47.5) | 60 | (49.2) | 118 | (48.4) | 0.726 |
Overweight | 53 | (43.4) | 48 | (39.3) | 101 | (41.4) | |
Obese | 11 | (9.0) | 14 | (11.5) | 25 | (10.2) |